La inmunogenicidad de los anticuerpos monoclonales contra el factor de necrosis tumoral utilizada en las enfermedades inflamatorias autoinmunes crónicas: revisión sistemática y meta-análisis

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2013
Cargando información sobre las referencias

CRD SUMMARY:

This review found that the development of antibodies against anti-TNF monoclonal antibodies increase risk of treatment discontinuation and hypersensitivity and may decrease clinical response. Combining monoclonal antibodies with other agents reduced the development of antibodies. The evidence was variable in quantity and quality, being more limited for efficacy outcomes, but the main conclusions appear reliable.
Epistemonikos ID: d7b383fdd8d1d3f3b76480194f645a3beff66c71
First added on: Oct 21, 2013